Chemical Compound

Anacyclamide A20P

Anacyclamide A20P chemical structure
Primary Record

Anacyclamide A20P

Note: Only for scientific research or as raw materials for production.

In stock
550 g
Purity
98.1 %

Compound Identifiers & Properties

PubChem CID
146684861
SMILES
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N1)[C@@H](C)O)CC(C)C)CC(C)C)CCCCN)CC3=CNC4=CC=CC=C43)CC(=O)O)CC(C)C)[C@@H](C)O)CC(=O)N)CC5=CNC6=CC=CC=C65)CO)C)CO
Canonical SMILES
CC[C@H](C)[C@@H]1NC(=O)CNC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC1=O

Names & Synonyms

  • Anacyclamide A20P
  • RefChem:112484
  • CHEBI:221755
  • 2-[(3S,6S,9S,12S,21S,24S,27S,30S,33S,36S,39S,45S,51S,57S,60S)-30-(4-aminobutyl)-51-(2-amino-2-oxoethyl)-12-[(2S)-butan-2-yl]-21,45-bis[(1R)-1-hydroxyethyl]-3,9-bis(hydroxymethyl)-33,57-bis(1H-indol-3-ylmethyl)-6-methyl-24,27,39-tris(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59-icosaoxo-1,4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58-icosazabicyclo[58.3.0]trihexacontan-36-yl]acetic acid
  • 2-((3S,6S,9S,12S,21S,24S,27S,30S,33S,36S,39S,45S,51S,57S,60S)-30-(4-aminobutyl)-51-(2-amino-2-oxoethyl)-12-((2S)-butan-2-yl)-21,45-bis((1R)-1-hydroxyethyl)-3,9-bis(hydroxymethyl)-33,57-bis(1H-indol-3-ylmethyl)-6-methyl-24,27,39-tris(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59-icosaoxo-1,4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58-icosazabicyclo(58.3.0)trihexacontan-36-yl)acetic acid
  • 2-((3S,9S,15S,21S,24S,27S,30S,33S,36S,39S,48S,51S,54S,57S,62AS)-30-(4-aminobutyl)-48-((2S)-butan-2-yl)-1,4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55-nonadecahydroxy-9-((C-hydroxycarbonimidoyl)methyl)-15,39-bis((1R)-1-hydroxyethyl)-51,57-bis(hydroxymethyl)-3,27-bis((1H-indol-3-yl)methyl)-54-methyl-21,33,36-tris(2-methylpropyl)-58-oxo-3H,6H,9H,12H,15H,18H,21H,24H,27H,30H,33H,36H,39H,42H,45H,48H,51H,54H,57H,58H,60H,61H,62H,62ah-pyrrolo(1,2-a)1,4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58-icosaazacyclohexacontan-24-yl)acetate
  • 2-[(3S,9S,15S,21S,24S,27S,30S,33S,36S,39S,48S,51S,54S,57S,62AS)-30-(4-aminobutyl)-48-[(2S)-butan-2-yl]-1,4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55-nonadecahydroxy-9-[(C-hydroxycarbonimidoyl)methyl]-15,39-bis[(1R)-1-hydroxyethyl]-51,57-bis(hydroxymethyl)-3,27-bis[(1H-indol-3-yl)methyl]-54-methyl-21,33,36-tris(2-methylpropyl)-58-oxo-3H,6H,9H,12H,15H,18H,21H,24H,27H,30H,33H,36H,39H,42H,45H,48H,51H,54H,57H,58H,60H,61H,62H,62ah-pyrrolo[1,2-a]1,4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58-icosaazacyclohexacontan-24-yl]acetate